Global Crown Capital Hosts Exclusive Nanotechnology Investment Conference for Institutional Investors
Conference speakers will include CEOs and CFOs of leading public companies involved in the development and use of Nanotechnology, senior executives of several later stage private Nanotech companies, select industry thought leaders and Global Crown Capital's All-Star Analyst team. A sample of confirmed companies include: Affymetrix, Agilent Technologies, Harris & Harris Group, Nanophase Technologies, NVE Corp., Symyx Technologies, Intel Capital and BASF Venture Capital.
“Nanotechnology is rapidly proliferating through different sectors of the global economy similarly to the Internet expansion during the early to mid 1990s. Nanotech is becoming an essential part of the business activities in the semiconductor manufacturing, pharmaceutical, chemical and even in the personal care and consumer non-durable sectors.”
The conference is tailored for Institutional Investors and the topics will therefore address an analysis of Nanotech sector opportunities and investment ideas for publicly traded Nanotechnology and MEMs companies. Discussions will include selections of nanotech investments including analysis of their addressed markets, business models and valuations as well as recommendations for opportunistic trading and portfolio management of Nanotechnology stocks.
The plenary sessions of the conference will be followed by dinner meetings with leading edge users of Nanotechnology, such as Broadcom (BRCM) and Texas Instruments (TXN). The following day, Oct. 31st, there will bus tours to Silicon Valley to visit semiconductor companies such as Marvell Technology Group (MRVL).
Rani Jarkas, Managing Director and Chief Investment Officer of Global Crown Capital said, "We are delighted to offer a select group of institutions a very focused and valuable summit on investing in Nanotech public equities. We believe that Nanotechnology is a new sector whose inclusion in a portfolio offers high growth potential with minimal to no correlation with the S&P 500."
Global Crown Capital is uniquely qualified to host this conference, as one of the leading investment firms in the U.S. focused on Nanotechnology. The firm has an unparalleled team of internal Nanotechnology experts, a pure-play Nanotechnology index -- currently used as a benchmark by professional investors -- and it publishes some of the only systematic research of public Nanotech equities worldwide.
Dr. Nikolay Tishchenko, Senior Managing Director of Global Equity Research at GCC, a physicist with nearly two decades of Nanotechnology expertise, said "Nanotechnology is rapidly proliferating through different sectors of the global economy similarly to the Internet expansion during the early to mid 1990s. Nanotech is becoming an essential part of the business activities in the semiconductor manufacturing, pharmaceutical, chemical and even in the personal care and consumer non-durable sectors.
"We believe that Nanotechnology could potentially repeat the impact of the Internet on the economic and financial markets and thus it is important for Institutional Investors to realize how Nanotech and its sub sectors, such as Nanomaterials, NanoTools, BioNano and Nanoelectronics are relevant and important to the performance of their portfolios," added Dr. Tishchenko.
About Global Crown Capital, LLC
Global Crown Capital is a full-service boutique investment firm specializing in institutional services including Global Equity Research, Hedge Fund and Asset Management Services and Institutional Sales & Trading. GCC is a member of the NASD and SIPC. For more information, contact Loulie Genato at 415-354-7191 or email@example.com or visit www.globalcrowncapital.com.